The Annual General Meeting of Gerresheimer approved the main proposed resolutions with high approval rates and ratified the actions of the Management and Supervisory Boards.
Gerresheimer will pay a dividend of EUR 0.04 for the financial year 2024. The Annual General Meeting thus approved the company’s new proposal for the appropriation of profits. In his speech, CEO Dietmar Siemssen emphasised the progress made on important strategic issues in 2024. He mentioned the acquisition of Bormioli Pharma, the successful implementation of growth projects, new long-term orders and the expansion of the portfolio to include further High Value Solutions. He drew particular attention to the increase in the share of revenues generated by solutions for biologics, including GLP-1-based drugs for the treatment of obesity.
Reduced dividend of EUR 0.04
In view of the guidance adjustment for the 2025 financial year, the Management Board and Supervisory Board had put a new proposal for the appropriation of profits to the vote at the Annual General Meeting in order to maintain the company’s financial flexibility. The Annual General Meeting approved the new proposal for the appropriation of profits by a large majority. Instead of EUR 1.25 per share, the company will now pay EUR 0.04 per share, which corresponds to the minimum dividend of 4 percent of the share capital.
High attendance and approval
With 72.40 percent of the share capital present, the Annual General Meeting approved key voting items. The actions of the Management Board and Supervisory Board were ratified by a large majority, the remuneration report and the new remuneration system for the Supervisory Board were approved and new authorised and conditional capital was created. KPMG AG Wirtschaftsprüfungsgesellschaft, Düsseldorf, was elected as the auditor for the 2025 financial year. The proposed system for Management Board remuneration did not receive a majority. It will be reviewed and put to the vote again at the 2026 Annual General Meeting.
Detailed voting results of the Annual General Meeting and the CEO speech at the Annual General Meeting can be found here.
The annual report can be found here.